Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain
Katarzyna Szczepańska, Tadeusz Karcz, Maria Dichiara, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9658-9683
Open Access | Times Cited: 11

Showing 11 citing articles:

Histamine H3 receptor blockade alleviates neuropathic pain through the regulation of glial cells activation
Maciej Degutis, Dorota Łażewska, Justyna Barut, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117850-117850
Closed Access
Recent Advances in the Development of Sigma Receptor (Radio)Ligands and Their Application in Tumors
Tao Wang, Na Sun, Yuefeng Ma, et al.
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 4, pp. 951-977
Closed Access
Cholinesterase-based inhibitors as multitarget small molecules for the therapy of Alzheimer’s disease
José Marco‐Contelles, María Jesús Oset‐Gasque
Chemico-Biological Interactions (2025), pp. 111497-111497
Closed Access
Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca2+ Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties
Irène Pachón-Angona, Paul J. Bernard, Alexey Simakov, et al.
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 121-121
Open Access | Times Cited: 2
Mechanism and therapeutic targets of the involvement of a novel lysosomal proton channel TMEM175 in Parkinson's disease
Tingting feng, Hongcheng zheng, Z. G. Zhang, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102373-102373
Closed Access | Times Cited: 2
Novel object recognition test as an alternative approach to assessing the pharmacological profile of sigma-1 receptor ligands
Katarzyna Szczepańska, Andrzej J. Bojarski, Piotr Popik, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 5, pp. 1291-1298
Open Access | Times Cited: 4
AR71, Histamine H3 Receptor Ligand—In Vitro and In Vivo Evaluation (Anti-Inflammatory Activity, Metabolic Stability, Toxicity, and Analgesic Action)
Anna Stasiak, Ewelina Honkisz-Orzechowska, Z Gajda, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8035-8035
Open Access | Times Cited: 1
SIGMAP: an explainable artificial intelligence tool for SIGMA-1 receptor affinity Prediction
Maria Cristina Lomuscio, Nicola Corriero, Vittoria Nanna, et al.
RSC Medicinal Chemistry (2024)
Open Access
Molecular Transformers: Adaptive Multitarget Ligands for Esterase-Induced Transition from Analgesics to Anesthetics
Tianguang Huang, Chi Song, Yuhao Chen, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
Guanidine Derivative ADS1017, a Potent Histamine H3 Receptor Antagonist with Promising Analgesic Activity and Satisfactory Safety Profile
Tadeusz Karcz, Katarzyna Szczepańska, Szczepan Mogilski, et al.
ACS Chemical Neuroscience (2024)
Closed Access
Histamine H 3 receptor antagonists/inverse agonists: a patent review (October 2017- December 2023) documenting progress
Dorota Łażewska, Katarzyna Kieć‐Kononowicz
Expert Opinion on Therapeutic Patents (2024), pp. 1-25
Open Access
Page 1

Scroll to top